Colorectal cancer (metastatic) - bevacizumab: response to consultee, commentator and public comments on the ACD and comments from website consultation
Colorectal cancer (metastatic) - bevacizumab: response to consultee, commentator and public comments on the first ACD and comments from website consultation (Issued November 2009)
Colorectal cancer (metastatic) - bevacizumab: response to consultee, commentator and public comments on the second ACD and comments from website consultation (Issued August 2010)
This page was last updated: 09 November 2010